LNWTC
KZIA

Laird Norton Wetherby Trust Company’s Kazia Therapeutics KZIA Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.3K Buy
+12,400
New +$86.3K ﹤0.01% 978

Other funds holding KZIA

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Laird Norton Wetherby Trust Company's KZIA Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company opened a new position in Kazia Therapeutics (KZIA) in Q1 2026: 12,400 shares worth $92.3K. The stake represents ﹤0.01% of the portfolio and ranks #978 among its holdings.

23 funds tracked by Wall St. Rank hold KZIA as of Q1 2026.

  • Laird Norton Wetherby Trust Company held 12,400 shares of Kazia Therapeutics worth $92.3K as of Q1 2026.
  • Kazia Therapeutics was a new Laird Norton Wetherby Trust Company position in Q1 2026.
  • Kazia Therapeutics made up ﹤0.01% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #978 holding.
  • 23 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.